Series A · Medtech & Devices · Leuven, Belgium · 11–50 employees
ElmediX is a Belgian oncology medtech company (University of Antwerp spin-off) developing controlled hyperthermal therapy platforms (e.g., TempoCure®) to enhance conventional cancer treatments such as chemo- and radiotherapy, with ongoing clinical studies in pancreatic and solid tumors and a planned Series A funding round of up to €5M to scale clinical evidence.
No open roles listed right now.